Random and site-specific radiolabeling of [89Zr]Zr-DFO-anti-PD-L1-mAb iPET tracer-Reference-Cited by-同舟云学术

Random and site-specific radiolabeling of [89Zr]Zr-DFO-anti-PD-L1-mAb iPET tracer

Published:2024-02-27 Issue: Volume: Page:
ISSN:0236-5731
Container-title:Journal of Radioanalytical and Nuclear Chemistry
language:en
Short-container-title:J Radioanal Nucl Chem

Author:

Lin Yi-Ching,Yang Chao-Wei,Tsai Shih-Chuan,Farn Shiou-Shiow,Ou Yang Fang-Yu,Lo Wei-Lin,Chen Liang-Cheng,Chen Kuo-Ting,Weng Mao-Chi,Kung Jui-Yin,Qiu Xin-Yu,Lu Ching-Chun,Huang Feng-Yun J.^ORCID

Funder

Taichung Veterans General Hospital/Central Taiwan University of Science and Technology Joint Research Program

Cheng Ching Hospital-Chung Kang Branch/Central Taiwan University of Science and Technology Joint Research Program

Ministry of Science and Technology and Atomic Energy Council in Taiwan for the mutual fund grant

Central Taiwan University of Science and Technology

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10967-024-09401-0.pdf

Reference31 articles.

1. Robert C (2020) A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun 11:3801. https://doi.org/10.1038/s41467-020-17670-y

2. Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227–242. https://doi.org/10.1038/nri3405

3. Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321–330. https://doi.org/10.1038/nature21349

4. Cai X, Zhan H, Ye Y, Yang J, Zhang M, Li J, Zhuang Y (2021) Current progress and future perspectives of immune checkpoint in cancer and infectious diseases. Front Genet 12:785153. https://doi.org/10.3389/fgene.2021.785153

5. Marin-Acevedo JA, Kimbrough EO, Lou Y (2021) Next generation of immune checkpoint inhibitors and beyond. J Hematol Oncol 14:45. https://doi.org/10.1186/s13045-021-01056-8